Industry News
Related Searches:
Filter by:
September 17, 2009
QPS Taiwan has been awarded a GLP lab certification by the Department of Health (DOH), Executive Yuan, R.O.C. (Taiwan).
Read More »
September 16, 2009
Bristol-Myers Squibb Co. has reached an agreement for the sale of its OTC assets in Asia Pacific (excluding China and Japan) to Taisho Pharmaceutical Co., Ltd. for $310 million.
Read More »
September 16, 2009
PPD, Inc. has opened its global central lab facility in Singapore to provide customized lab services in Southeast Asia.
Read More »
September 15, 2009
Alcon has entered into a definitive agreement to acquire ESBATech AG for $150 million in cash at closing, plus achievement-based R&D payments of as much as $439 million.
Read More »
September 14, 2009
Lilly has announced plans to restructure and shave $1 billion from its operating costs
Read More »
September 11, 2009
QPharma, Inc., has opened its Specialized Pharmacy, QPharmaRx. The company currently manages fulfillment programs for clients that engage in Patient Assistance Programs that target both patients and practitioners.
Read More »
September 10, 2009
Lonza Group broke ground at Tuas Biomedical Park in Singapore for the new facility for its Cell Therapy business.
Read More »
September 9, 2009
Advion BioServices, Inc. has expanded its LC/MS Biomarker Services Group in response to increased interest in the use of biomarkers in drug development.
Read More »
September 3, 2009
Pfizer has agreed to plead guilty to a U.S. criminal charge relating to promotion of Bextra, a pain medicine that is now withdrawn from the market.
Read More »
September 3, 2009
Dainippon Sumitomo Pharma Co., Ltd. and Sepracor Inc. have entered into a definitive agreement under which DSP will acquire Sepracor for approximately $2.6 billion in cash.
Read More »
September 2, 2009
MDS, Inc. has entered into an agreement to sell its Analytical Technologies business to Danaher Corp. for $650 million in cash.
Read More »
September 2, 2009
Tioga Pharmaceuticals and Ono Pharmaceutical Co., Ltd. have entered an exclusive license agreement under which Ono has licensed rights to develop and commercialize asimadoline in Japan, South Korea and Taiwan.
Read More »
September 1, 2009
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has completed a successful audit of Cobra Biomanufacturing’s facility in Keele.
Read More »
August 28, 2009
Orexo has signed an exclusive worldwide licensing agreement with a Novartis affiliate to develop and commercialize a new product related to Orexo’s OX17 program. OX17, a combination of an H2-receptor blocker and a proton-pump inhibitor, is being stu
Read More »
August 27, 2009
Biolex Therapeutics has entered into an agreement with Cook Pharmica under which Cook will manufacture drug substance for use in Biolex's Phase III trials of Locteron.
Read More »
